EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY 4.0

Validation of a qualitative real-time PCR assay for the detection of Candida auris in hospital inpatient screening

Lauren C Franco, Mahmoud Ahmed, Christopher G Kendra, R Matthew Sperling, Kayla Van Benten, John-Paul Lavik, Christopher L Emery, Ryan F Relich iD, Kenneth Gavina iD

Journal of Clinical Microbiology · 2024

DOI: 10.1128/jcm.00158-24 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Journal of Clinical Microbiology, 2024. Verfasst von Lauren C Franco und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA. Hauptthemen laut MEDLINE: Real-Time Polymerase Chain Reaction, Sensitivity and Specificity, Candidiasis, Candida auris. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Candida auris is a multidrug-resistant opportunistic fungal pathogen capable of causing serious infections and healthcare-associated outbreaks. Screening for colonization with C. auris has become routine and is recommended in many hospitals and healthcare facilities as an infection control and prevention strategy. Subsequently, and since there are currently no FDA-approved tests for this purpose, clinical microbiology laboratories have become responsible for developing protocols to detect C. auris using axial and inguinal screening swabs. In a College of American Pathologists-accredited large academic healthcare center setting, we implemented a laboratory-developed nucleic-acid amplification test for the detection of C. auris DNA. Our test validation evaluated the performance of the DiaSorin C. auris primer set used in a real-time qualitative PCR assay on the LIAISON MDX thermocycler with the Simplexa Universal Disc. The assay was highly sensitive and specific, with a limit of detection of 1–2 CFU/reaction, with no observed cross-reactivity with other Candida spp., bacterial skin commensal organisms or commonly encountered viruses. When run in parallel with a culture-based detection method, the PCR assay was 100% sensitive and specific. The assay was precise, with low variability between replicates within and between runs. Lastly, pre-analytical factors, including swab storage time, temperature, and transport media, were assessed and found to have no significant effect on the detection of C. auris at variable concentrations. Taken together, this study expands the available options for nucleic acid detection of C. auris and characterizes pre-analytical factors for implementation in both high- and low-volume laboratory settings. IMPORTANCE This study overviews the validation and implementation of a molecular screening tool for the detection of Candida auris in a College of American Pathologist-accredited clinical laboratory. This molecular laboratory-developed test is both highly sensitive and specific and has significant health-system cost-savings associated with significantly reduced turn-around-time compared to traditional standard-of-care culture-based work up. This method and workflow is of interest to support clinical microbiology diagnostics and to help aid in hospital inpatient, and infection prevention control screening.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Real-Time Polymerase Chain ReactionSensitivity and SpecificityCandidiasisCandida aurisHumansMass ScreeningInpatientsMolecular Diagnostic TechniquesHospitalsCandidaDNA, Fungal

Stichwörter der Autor:innen

Candida aurishospital infectionsinfectious diseasemolecular methodsmycologypublic health

Substanzen

DNA, Fungal

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Division of Clinical Microbiology, Indiana University Health, Indianapolis, Indiana, USA.

ORCID-Profile: Ryan F Relich, Kenneth Gavina

Zitieren

APA

Franco, L. C., Ahmed, M., Kendra, C. G., Sperling, R. M., Van Benten, K., Lavik, J. P., Emery, C. L., Relich, R. F., & Gavina, K. (2024). Validation of a qualitative real-time PCR assay for the detection of Candida auris in hospital inpatient screening. Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.00158-24

Vancouver

Franco LC, Ahmed M, Kendra CG, Sperling RM, Van Benten K, Lavik JP, et al. Validation of a qualitative real-time PCR assay for the detection of Candida auris in hospital inpatient screening. Journal of Clinical Microbiology. 2024. doi:10.1128/jcm.00158-24

BibTeX
@article{Franco2024,
  author = {Franco, Lauren C and Ahmed, Mahmoud and Kendra, Christopher G and Sperling, R Matthew and Van Benten, Kayla and Lavik, John-Paul and Emery, Christopher L and Relich, Ryan F and Gavina, Kenneth},
  title = {Validation of a qualitative real-time PCR assay for the detection of Candida auris in hospital inpatient screening},
  journal = {Journal of Clinical Microbiology},
  year = {2024},
  doi = {10.1128/jcm.00158-24}
}
Kostenlos starten →